[et_pb_section fb_built=”1″ admin_label=”section” _builder_version=”4.16″ custom_padding=”||0px|||” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ custom_padding=”12px|||||” locked=”off” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ text_font=”||||||||” header_font=”Roboto||||||||” header_text_color=”#323232″ header_font_size=”40px” header_line_height=”1.2em” max_width=”85%” module_alignment=”center” custom_margin=”||19px|||” global_colors_info=”{}”]<\/p>\n
[\/et_pb_text][et_pb_divider color=”#003389″ divider_weight=”3px” _builder_version=”4.16″ width=”100%” max_width=”21%” module_alignment=”left” custom_margin=”|||0px|false|false” custom_padding=”|||80px|false|false” global_colors_info=”{}”][\/et_pb_divider][et_pb_image src=”https:\/\/blogs.lshtm.ac.uk\/iceh-new\/files\/2025\/12\/WhatsApp-Image-2024-06-27-at-23.55.02.jpeg” alt=”a group of people stand around a table at a conference centre, looking at a large process diagram” title_text=”WhatsApp-Image-2024-06-27-at-23.55.02″ _builder_version=”4.27.4″ _module_preset=”default” width=”85%” module_alignment=”center” custom_margin=”-15px||||false|false” global_colors_info=”{}”][\/et_pb_image][et_pb_text quote_border_color=”#003389″ _builder_version=”4.27.4″ text_font=”|600|||||||” text_text_color=”#323232″ link_text_color=”#3344dd” quote_font_size=”20px” header_font=”Roboto||||||||” header_text_color=”#323232″ max_width=”85%” module_alignment=”center” min_height=”88px” custom_margin=”-4px||15px|||” custom_padding=”0px||4px|||” hover_enabled=”0″ global_colors_info=”{}” text_font_size=”16px” sticky_enabled=”0″]<\/p>\n
Vision impairment affects more than 1.1 billion people worldwide, most of whom live in low- and middle-income countries and have conditions that are preventable or treatable with existing, cost-effective interventions. Despite substantial progress in eye health research and service delivery, major evidence gaps continue to limit countries\u2019 ability to provide equitable, high-quality care.<\/p>\n
In response to a mandate from the World Health Assembly, the World Health Organization (WHO) is developing a Global Eye Health Research Agenda to align research efforts with population needs and strengthen decision-making at national and global levels. The initiative is coordinated by ICEH, acting as WHO\u2019s technical collaborator, and aims to identify the most important research questions across priority themes. A central goal is to generate evidence that can inform policies, close gaps in service delivery, and advance innovation and equity so that more people can benefit from effective eye care.<\/p>\n
The Agenda is being developed using a structured, multi-phase, and globally inclusive approach aligned with WHO guidance for research priority-setting. ICEH and WHO have convened diverse stakeholder groups, including people with lived experience, clinicians, programme implementers, researchers, and policymakers from all WHO regions to contribute to the process.<\/p>\n